Strs Ohio Acquires 25,204 Shares of STERIS plc $STE

Key Points

• Strs Ohio boosted its stake in STERIS by 62.5% in Q4, buying 25,204 shares to hold 65,552 shares worth about $16.62 million (roughly 0.07% of the company).
• Several large institutions also upped positions—AQR grew holdings 178.6% to 1,183,070 shares and others (Orbis, Thrivent, Mitsubishi UFJ) made sizable buys—leaving institutional investors with about 94.69% ownership.
• Analysts have a consensus rating of “Moderate Buy” with a $275.20 price target; STERIS reported matching-quarter EPS and set FY2026 guidance of $10.15–$10.30 (sell-side expects $10.22), with a market cap around $21.06 billion and a P/E near 30.

Strs Ohio increased its position in STERIS plc (NYSE:STE - Free Report) by 62.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 65,552 shares of the medical equipment provider's stock after acquiring an additional 25,204 shares during the period. Strs Ohio owned about 0.07% of STERIS worth $16,619,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of STE. AQR Capital Management LLC grew its holdings in shares of STERIS by 178.6% in the third quarter. AQR Capital Management LLC now owns 1,183,070 shares of the medical equipment provider's stock worth $291,704,000 after acquiring an additional 758,423 shares during the period. Boston Partners bought a new stake in shares of STERIS in the third quarter worth $158,982,000. Orbis Allan Gray Ltd grew its holdings in shares of STERIS by 36.0% in the second quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider's stock worth $504,486,000 after acquiring an additional 556,088 shares during the period. Thrivent Financial for Lutherans grew its holdings in shares of STERIS by 246.4% in the third quarter. Thrivent Financial for Lutherans now owns 553,834 shares of the medical equipment provider's stock worth $137,041,000 after acquiring an additional 393,970 shares during the period. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in shares of STERIS by 16.4% in the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,567,238 shares of the medical equipment provider's stock worth $387,797,000 after acquiring an additional 221,199 shares during the period. Institutional investors own 94.69% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on STE shares. Weiss Ratings lowered STERIS from a "buy (b-)" rating to a "hold (c+)" rating in a report on Thursday, April 16th. Wall Street Zen lowered STERIS from a "strong-buy" rating to a "buy" rating in a report on Sunday, April 26th. Five equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $275.20.

STERIS Price Performance

NYSE STE opened at $214.78 on Monday. The company has a market capitalization of $21.06 billion, a PE ratio of 29.96 and a beta of 0.95. The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.75 and a current ratio of 2.48. The business's fifty day moving average is $226.36 and its 200 day moving average is $244.80. STERIS plc has a fifty-two week low of $209.98 and a fifty-two week high of $269.44.

STERIS (NYSE:STE - Get Free Report) last released its earnings results on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, meeting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.The firm's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $2.32 EPS. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Sell-side analysts predict that STERIS plc will post 10.22 earnings per share for the current year.

Insiders Place Their Bets

In related news, Director Cynthia L. Feldmann sold 3,098 shares of STERIS stock in a transaction on Thursday, March 5th. The stock was sold at an average price of $237.21, for a total transaction of $734,876.58. Following the transaction, the director directly owned 705 shares in the company, valued at approximately $167,233.05. The trade was a 81.46% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 1.07% of the company's stock.

STERIS Company Profile

STERIS Corporation NYSE: STE is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.